DRD
CLLS

Dennis R. Delaney’s Cellectis CLLS Stock Holding History

Dennis R. Delaney’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72K Hold
24,000
– – 0.02% 60
2026
Q1 		$76.1K Hold
24,000
– – 0.03% 59
2025
Q4 		$116K Hold
24,000
– – 0.06% 47
2025
Q3 		$68.4K Buy
+24,000
New +$62.2K 0.03% 48

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dennis R. Delaney's CLLS Position: Q2 2026 in Review

Dennis R. Delaney held its Cellectis (CLLS) position steady in Q2 2026 at 24,000 shares worth $72K. The position accounts for 0.02% of the portfolio, ranked #60.

Dennis R. Delaney first reported a position in CLLS in Q3 2025 and has held it in 4 quarters since. The position peaked at $116K in Q4 2025. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Dennis R. Delaney held 24,000 shares of Cellectis worth $72K as of Q2 2026.
  • Dennis R. Delaney left its Cellectis share count unchanged in Q2 2026.
  • Cellectis made up 0.02% of Dennis R. Delaney's portfolio in Q2 2026, its #60 holding.
  • Dennis R. Delaney first reported a position in Cellectis in Q3 2025 and has held it in 4 quarters since.
  • Dennis R. Delaney's Cellectis position peaked at $116K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Dennis R. Delaney's 13F filing for Q2 2026, filed 21 Aug 2026.